These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Arsenic trioxide inhibits cell growth and induces apoptosis through inactivation of notch signaling pathway in breast cancer. Xia J, Li Y, Yang Q, Mei C, Chen Z, Bao B, Ahmad A, Miele L, Sarkar FH, Wang Z. Int J Mol Sci; 2012 Mar 31; 13(8):9627-9641. PubMed ID: 22949821 [Abstract] [Full Text] [Related]
3. Targeting Notch Signaling and Autophagy Increases Cytotoxicity in Glioblastoma Neurospheres. Natsumeda M, Maitani K, Liu Y, Miyahara H, Kaur H, Chu Q, Zhang H, Kahlert UD, Eberhart CG. Brain Pathol; 2016 Nov 31; 26(6):713-723. PubMed ID: 26613556 [Abstract] [Full Text] [Related]
4. The impact of arsenic trioxide and all-trans retinoic acid on p53 R273H-codon mutant glioblastoma. Karsy M, Albert L, Murali R, Jhanwar-Uniyal M. Tumour Biol; 2014 May 31; 35(5):4567-80. PubMed ID: 24399651 [Abstract] [Full Text] [Related]
5. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro. You M, Varona-Santos J, Singh S, Robbins DJ, Savaraj N, Nguyen DM. J Thorac Cardiovasc Surg; 2014 Jan 31; 147(1):508-16. PubMed ID: 24094913 [Abstract] [Full Text] [Related]
6. Arsenic trioxide depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway. Wu J, Ji Z, Liu H, Liu Y, Han D, Shi C, Shi C, Wang C, Yang G, Chen X, Shen C, Li H, Bi Y, Zhang D, Zhao S. Toxicol Lett; 2013 Jun 20; 220(1):61-9. PubMed ID: 23542114 [Abstract] [Full Text] [Related]
7. Arsenic trioxide sensitizes glioblastoma to a myc inhibitor. Yoshimura Y, Shiino A, Muraki K, Fukami T, Yamada S, Satow T, Fukuda M, Saiki M, Hojo M, Miyamoto S, Onishi N, Saya H, Inubushi T, Nozaki K, Tanigaki K. PLoS One; 2015 Jun 20; 10(6):e0128288. PubMed ID: 26038891 [Abstract] [Full Text] [Related]
8. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth. Zhou W, Cheng L, Shi Y, Ke SQ, Huang Z, Fang X, Chu CW, Xie Q, Bian XW, Rich JN, Bao S. Oncotarget; 2015 Nov 10; 6(35):37300-15. PubMed ID: 26510911 [Abstract] [Full Text] [Related]
9. Arsenic trioxide regulates the apoptosis of glioma cell and glioma stem cell via down-regulation of stem cell marker Sox2. Sun H, Zhang S. Biochem Biophys Res Commun; 2011 Jul 08; 410(3):692-7. PubMed ID: 21703238 [Abstract] [Full Text] [Related]
10. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition. Ying M, Wang S, Sang Y, Sun P, Lal B, Goodwin CR, Guerrero-Cazares H, Quinones-Hinojosa A, Laterra J, Xia S. Oncogene; 2011 Aug 04; 30(31):3454-67. PubMed ID: 21383690 [Abstract] [Full Text] [Related]
11. microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells. Meng XZ, Zheng TS, Chen X, Wang JB, Zhang WH, Pan SH, Jiang HC, Liu LX. J Gastroenterol Hepatol; 2011 Jan 04; 26(1):186-93. PubMed ID: 21175813 [Abstract] [Full Text] [Related]
12. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. Schreck KC, Taylor P, Marchionni L, Gopalakrishnan V, Bar EE, Gaiano N, Eberhart CG. Clin Cancer Res; 2010 Dec 15; 16(24):6060-70. PubMed ID: 21169257 [Abstract] [Full Text] [Related]
13. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG. Stem Cells; 2010 Jan 15; 28(1):5-16. PubMed ID: 19904829 [Abstract] [Full Text] [Related]
14. Targeting of EGFR increase anti-cancer effects of arsenic trioxide: Promising treatment for glioblastoma multiform. Mesbahi Y, Zekri A, Ahmadian S, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. Eur J Pharmacol; 2018 Feb 05; 820():274-285. PubMed ID: 29274334 [Abstract] [Full Text] [Related]
15. Arsenic trioxide-mediated Notch pathway inhibition depletes the cancer stem-like cell population in gliomas. Zhen Y, Zhao S, Li Q, Li Y, Kawamoto K. Cancer Lett; 2010 Jun 01; 292(1):64-72. PubMed ID: 19962820 [Abstract] [Full Text] [Related]
16. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions. Fang KM, Lin TC, Chan TC, Ma SZ, Tzou BC, Chang WR, Liu JJ, Chiou SH, Yang CS, Tzeng SF. Glia; 2013 Sep 01; 61(9):1402-17. PubMed ID: 23832679 [Abstract] [Full Text] [Related]
17. Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1. Kerl K, Moreno N, Holsten T, Ahlfeld J, Mertins J, Hotfilder M, Kool M, Bartelheim K, Schleicher S, Handgretinger R, Schüller U, Meisterernst M, Frühwald MC. Int J Cancer; 2014 Aug 15; 135(4):989-95. PubMed ID: 24420698 [Abstract] [Full Text] [Related]
18. Arsenic trioxide prevents osteosarcoma growth by inhibition of GLI transcription via DNA damage accumulation. Nakamura S, Nagano S, Nagao H, Ishidou Y, Yokouchi M, Abematsu M, Yamamoto T, Komiya S, Setoguchi T. PLoS One; 2013 Aug 15; 8(7):e69466. PubMed ID: 23861973 [Abstract] [Full Text] [Related]
19. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal. Li Y, Jiang F, Liu Q, Shen J, Wang X, Li Z, Zhang J, Lu X. Toxicol Sci; 2015 Jan 15; 143(1):156-64. PubMed ID: 25304214 [Abstract] [Full Text] [Related]
20. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24. Cao Y, Yu SL, Wang Y, Guo GY, Ding Q, An RH. Tumour Biol; 2011 Feb 15; 32(1):179-88. PubMed ID: 20857258 [Abstract] [Full Text] [Related] Page: [Next] [New Search]